AzTrials
AzTrials

Resting Metabolic RateMEDGEMNCT03035903

Energy Cost for Holding a MedGem® Indirect Calorimeter

A study testing Not holding, then holding the MedGem® and Holding, then not holding the MedGem® in people with Resting Metabolic Rate, run by Pennington Biomedical Research Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RMR) compared to not holding the MedGem® device. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Resting Metabolic Rate
What is being tested?
Not holding, then holding the MedGem® and Holding, then not holding the MedGem®
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
13 Feb 2017to 31 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age between 18-65 y
  • BMI 25-40 kg/m2

Who cannot join

  • Diabetes mellitus
  • Current smoker
  • Presently on a weight loss regimen
  • Medications: diabetes, oral steroids, blood pressure drugs, weight loss drugs
  • Claustrophobia
  • Pregnant or breastfeeding
Show all 9Show fewer
  • Congestive heart failure
  • Chronic kidney disease
  • Pacemaker or other metal implants

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, 70808

Other trials in United States

About this study

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RMR) compared to not holding the MedGem® device.

Read the detailed description

Forty (40) subjects will be randomized to two (2) RMR measurements separated by a 40-minute rest (washout) period. The two RMR evaluation periods are as follows:

  1. RMR with MedGem® Indirect Calorimeter
  2. RMR without MedGem® Indirect Calorimeter

Study recruitment will be performed at PBRC. Screening, consenting, and all study procedures will be performed within a single study visit at PBRC within the Inpatient Unit. All subjects will be introduced to the ventilated hood to determine presence of claustrophobia prior to enrollment (i.e., signing of the consent form).

Being tested
Not holding, then holding the MedGem®, Holding, then not holding the MedGem®

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Not holding, then holding the MedGem®Device

    Subjects will have a RMR measurement taken first while not holding the MedGem®, and then while holding the MedGem®

  • Holding, then not holding the MedGem®Device

    Subjects will have a RMR measurement taken first while holding the MedGem®, and then while not holding the MedGem®

Study groups in NCT03035903
Study groupRoleWhat they receive
Not holding, then holding the MedGem®ExperimentalSubjects will be seated in an armless chair and have a RMR measurement taken while not holding, then holding a MedGem® Indirect Calorimeter.
Receives: Device: Not holding, then holding the MedGem®; Device: Holding, then not holding the MedGem®
Holding, then not holding the MedGem®Active comparatorSubjects will be seated in an armless chair and have a RMR measurement taken holding, then not holding a MedGem® Indirect Calorimeter.
Receives: Device: Not holding, then holding the MedGem®; Device: Holding, then not holding the MedGem®

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resting Metabolic Rate (RMR)

    Resting metabolic rate will be assessed via a DeltaTrac Metabolic Cart

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2017 (estimated)
  2. Study start13 Feb 2017
  3. Primary completion31 Dec 2017
  4. Study completion31 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03035903
Sponsor's protocol ID
PBRC 2016-086
Acronym
MEDGEM
Status last verified
Jun 2018
First submitted
26 Jan 2017
Last updated
6 Jun 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data will be not be shared outside of Weight Watchers and the Investigators listed on the protocol for this study.

Questions about this trial

What is this clinical trial studying?

A study testing Not holding, then holding the MedGem® and Holding, then not holding the MedGem® in people with Resting Metabolic Rate, run by Pennington Biomedical Research Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resting Metabolic Rate (RMR) (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in